Oncimmune (LON:ONC) Stock Price Down 8.5% – Time to Sell?

Oncimmune Holdings plc (LON:ONC) fell 8.5% during trading on Thursday . The company traded as low as GBX 11.80 ($0.14) and last traded at GBX 11.90 ($0.14). 1,445,113 shares changed hands during mid-day trading, an increase of 550% from the average session volume of 222,310 shares. The stock had previously closed at GBX 13 ($0.16).

Oncimmune Trading Up 5.6 %

The company has a quick ratio of 0.63, a current ratio of 1.13 and a debt-to-equity ratio of 806.85. The company has a market cap of £9.12 million, a price-to-earnings ratio of -410.00 and a beta of 1.19. The firm has a 50 day moving average price of GBX 14.69 and a two-hundred day moving average price of GBX 14.74.

Oncimmune Company Profile

Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.